Most sold healthcare stocks in Q2 2017
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2017, measured as net reductions in reported share positions from Q1 2017 into Q2 2017. Notable reductions at the top of this list include INNOVIVA INC (INVA), WALGREENS BOOTS ALLIANCE INC (WBA), TEVA PHARMACEUTICAL-SP ADR (TEVA), BAXTER INTERNATIONAL INC (BAX). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| INVA | INNOVIVA INC | -12,065,438 | -$169.62M | 0 | 0 | 1 | 2 | 1 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -8,811,674 | -$774.02M | 0 | 3 | 2 | 0 | 9 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -6,701,385 | -$214.29M | 0 | 2 | 0 | 2 | 3 |
| BAX | BAXTER INTERNATIONAL INC | -5,596,311 | $124.40M | 2 | 1 | 4 | 0 | 8 |
| SNY | SANOFI-ADR | -5,502,118 | -$70.09M | 0 | 0 | 4 | 0 | 6 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -2,875,140 | $18.11M | 0 | 0 | 2 | 0 | 2 |
| ABT | ABBOTT LABORATORIES | -2,803,053 | -$90.54M | 1 | 3 | 3 | 1 | 8 |
| ELV | ELEVANCE HEALTH INC | -2,757,974 | -$254.31M | 1 | 2 | 4 | 0 | 10 |
| MRK | MERCK & CO. INC. | -2,632,040 | -$153.70M | 1 | 3 | 7 | 0 | 15 |
| CNC | CENTENE CORP | -2,416,756 | -$156.26M | 0 | 1 | 1 | 1 | 2 |
| ALGN | ALIGN TECHNOLOGY INC | -2,101,744 | -$25.99M | 1 | 3 | 1 | 1 | 5 |
| JNJ | JOHNSON & JOHNSON | -1,826,968 | -$23.31M | 0 | 4 | 11 | 2 | 19 |
| NVS | NOVARTIS AG-SPONSORED ADR | -1,606,154 | $448.37M | 1 | 2 | 6 | 0 | 10 |
| BSX | BOSTON SCIENTIFIC CORP | -1,500,990 | -$14.74M | 0 | 0 | 4 | 0 | 4 |
| HUM | HUMANA INC | -1,414,578 | -$159.65M | 0 | 1 | 2 | 1 | 3 |
| DVA | DAVITA INC | -1,039,226 | -$196.18M | 0 | 2 | 1 | 1 | 4 |
| ACHC | ACADIA HEALTHCARE CO INC | -1,031,030 | -$44.95M | 0 | 0 | 0 | 2 | 0 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -1,006,600 | -$48.96M | 0 | 0 | 1 | 0 | 1 |
| TDOC | TELADOC HEALTH INC | -806,600 | $19.53M | 0 | 0 | 1 | 0 | 1 |
| BIIB | BIOGEN INC | -773,990 | -$213.28M | 0 | 3 | 2 | 2 | 5 |
| A | AGILENT TECHNOLOGIES INC | -770,100 | -$8.36M | 0 | 0 | 1 | 1 | 2 |
| ZTS | ZOETIS INC | -642,042 | $61.32M | 0 | 1 | 2 | 0 | 4 |
| SNN | SMITH & NEPHEW PLC -SPON ADR | -610,300 | -$18.39M | 0 | 0 | 1 | 0 | 1 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | -574,051 | -$3.42M | 0 | 0 | 0 | 1 | 0 |
| COR | CENCORA INC | -565,799 | -$18.30M | 0 | 1 | 1 | 1 | 2 |
| GKOS | GLAUKOS CORP | -565,500 | -$35.31M | 0 | 0 | 1 | 0 | 1 |
| MYGN | MYRIAD GENETICS INC | -532,365 | -$1.18M | 0 | 1 | 0 | 1 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | -528,505 | $53.85M | 2 | 4 | 5 | 0 | 15 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -508,711 | -$42.79M | 1 | 0 | 2 | 0 | 3 |
| HOLX | HOLOGIC INC | -423,634 | -$12.03M | 0 | 0 | 3 | 0 | 3 |
| INCY | INCYTE CORP | -410,797 | -$56.03M | 0 | 2 | 0 | 1 | 2 |
| CPIX | CUMBERLAND PHARMACEUTICALS | -396,135 | -$2.67M | 0 | 1 | 1 | 0 | 2 |
| RGEN | REPLIGEN CORP | -329,000 | -$9.71M | 0 | 0 | 1 | 0 | 1 |
| NEO | NEOGENOMICS INC | -308,664 | -$2.44M | 0 | 0 | 0 | 1 | 0 |
| DXCM | DEXCOM INC | -295,143 | -$25.01M | 0 | 0 | 0 | 1 | 0 |
| XRAY | DENTSPLY SIRONA INC | -286,004 | -$11.16M | 0 | 2 | 1 | 1 | 3 |
| UNH | UNITEDHEALTH GROUP INC | -270,100 | $472.08M | 2 | 6 | 8 | 0 | 17 |
| CMRX | CHIMERIX INC | -266,649 | -$1.74M | 0 | 0 | 1 | 0 | 1 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | -265,473 | $248.43M | 0 | 0 | 2 | 1 | 2 |
| HSIC | HENRY SCHEIN INC | -246,500 | -$41.00M | 0 | 0 | 1 | 0 | 2 |
| PBYI | PUMA BIOTECHNOLOGY INC | -206,500 | -$7.68M | 0 | 0 | 0 | 1 | 0 |
| FGEN | FIBROGEN INC | -192,800 | -$3.01M | 0 | 0 | 1 | 0 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | -181,372 | -$4.52M | 0 | 1 | 1 | 0 | 2 |
| ATR | APTARGROUP INC | -177,000 | -$12.92M | 0 | 0 | 1 | 0 | 2 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -169,500 | -$7.11M | 0 | 0 | 0 | 1 | 1 |
| IART | INTEGRA LIFESCIENCES HOLDING | -163,960 | -$6.79M | 0 | 0 | 1 | 0 | 1 |
| LFCR | LIFECORE BIOMEDICAL INC | -153,941 | -$372.00K | 0 | 0 | 1 | 0 | 1 |
| BDX | BECTON DICKINSON AND CO | -139,044 | $45.48M | 0 | 2 | 6 | 0 | 9 |
| PETS | PETMED EXPRESS INC | -138,915 | $30.91M | 0 | 0 | 1 | 0 | 1 |
| ALKS | ALKERMES PLC | -124,886 | -$7.31M | 0 | 0 | 0 | 1 | 0 |
Frequently asked questions about Most sold healthcare stocks in Q2 2017
What are the most sold Healthcare stocks in Q2 2017?
The most sold healthcare stocks in Q2 2017 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2017, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2017?
Among filers in this sector, net reductions were largest in companies such as INNOVIVA INC (INVA), WALGREENS BOOTS ALLIANCE INC (WBA), TEVA PHARMACEUTICAL-SP ADR (TEVA), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2017).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.